Adjuvant IO: Survival Advantage 'Big News' in Renal Cancer

1 year ago 44

A 40% reduced risk for death from renal cancer, as reported by KEYNOTE-564, tops Dr Brian Rini's list of takeaways from ASCO GU 2024. Also discussed are updates on doublet therapy in advanced disease.

1. Homepage
2. category-label-
3. Adjuvant IO: Survival Advantage 'Big News' in Renal Cancer